Press Releases

Third Quarter Results Notification & Call Information

Slough, UK, and Richmond, VA, 17 October 2018 – Indivior PLC (LON: INDV) today announced that it will release its 2018 third quarter and year-to-date results on Thursday, November 1st at 11:00 a.m. London time (7:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange’s Regulatory News Service (RNS) and on the “Investors” section of the company’s website at

Key members of Indivior’s leadership team led by Shaun Thaxter, Chief Executive Officer, will host a conference call to discuss the results and address questions from qualified analysts and investors at 12 noon London time (8:00 a.m. U.S. Eastern) on November 1st.

Access the Live Webcast for the Results Call on Thursday, November 1st

The webcast event will be available on the “Investors” section of the company’s website at The webcast link is Participants also may access the results presentation telephonically: US participants +1-929-477-0324; international participants +44(0)330-336-9105. Please reference confirmation number 4593067. A replay of the presentation will be available at

About Indivior

Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline “Focus on you” makes the Company’s commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit to learn more.

Jason Thompson
Vice President, Investor Relations
Tel: 804-379-1033 or